Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Avidity Biosciences
ISIN US05370A1088
|WKN A2P5NK
Market cap (in EUR)
9,252 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Advertisement
Capital at risk. Execution-only service.
Overview
Description
Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.
Healthcare Biopharmaceuticals Other Biopharmaceuticals United States
Financials
Key metrics
| Market capitalisation, EUR | 9,252 m |
| EPS, EUR | -3.78 |
| P/B ratio | 5.6 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 10 m |
| Net income, EUR | -298 m |
| Profit margin | -2,957.71% |
What ETF is Avidity Biosciences in?
There are 35 ETFs which contain Avidity Biosciences. All of these ETFs are listed in the table below. The ETF with the largest weighting of Avidity Biosciences is the Global X Genomics & Biotechnology UCITS ETF.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.